Amyris, Inc., a vertically integrated biomanufacturing company based in Emeryville, Calif., has announced that it will acquire Oobli Inc., a Davis, Calif.-based sweet-protein innovator whose fermentation-derived ingredients are designed to help food and beverage brands reduce sugar without sacrificing taste.
Amyris said the acquisition would bring together its scientific capabilities and manufacturing depth with Oobli’s protein fermentation expertise. The move follows Amyris’ expansion earlier this year of manufacturing capacity at its advanced fermentation facility in Barra Bonita, Brazil. Amyris described the acquisition as a strategic commercial and technology expansion intended to accelerate its presence in protein- and peptide-based solutions across end markets.
Complementary platforms
“In Oobli, we see a commercial and technology platform that is a great complement to our own,” Amyris CEO Kathy Fortmann said in the announcement. She said Amyris aims to bring commercial scale and resources to accelerate what the company calls the sweet revolution. By combining Oobli’s protein expertise with Amyris’ strain engineering, manufacturing scale and commercial capabilities, Fortmann said the companies see potential to broaden capabilities in food and beverage, personal care, flavor and fragrance, agriculture and other markets.
Oobli’s commercial portfolio of sweet proteins would be the first to benefit from the combined platform. Oobli has spent the past decade refining a fermentation process to produce sweet proteins naturally found in rare fruits and berries near the equator. According to the announcement, Oobli’s sweet proteins are the first of their kind in the sugar-reduction category. The companies say sweet proteins are hundreds to thousands of times sweeter than sugar, bind directly to sweet taste receptors and are metabolized by the body as protein, delivering sweetness without gut disruption or blood sugar spikes.
Portfolio and applications
Oobli’s portfolio includes Oubli Fruit, Serendipity Berry and Katemfe Fruit Sweet Proteins, scientifically known as brazzein, monellin and thaumatin, respectively. The portfolio has FDA GRAS status as an ingredient and is FEMA GRAS-affirmed for use as a natural flavor. With growing consumer awareness of metabolic health and the benefits of sugar reduction, the companies say sweet proteins can give brands a new tool to reduce sugar across categories including sports and nutrition, dairy, beverages, chocolate, bakery and confectionery.
Oobli CEO Ali Wing said the company has long believed there was a better way to deliver the sweet taste consumers love without trade-offs to health and the environment. She said joining forces with Amyris would give Oobli the scale and resources to pursue its ambition of making sweet proteins a global standard in sweetness solutions.
Fortmann added that Amyris has seen biomanufactured solutions succeed when they align with consumer demand and market needs. She said Oobli’s platform does that by giving brands a way to address sweet taste, sugar reduction and clean label at the same time. Amyris said it is excited to welcome the Oobli team and to realize synergies between the two platforms.
Closing and commitments
The acquisition is expected to close in the coming weeks. Amyris said that as Oobli’s sweet-protein portfolio continues to expand within the company, all existing customer commitments and brand partnerships will be honored without interruption.
